NQO1 Polyclonal Antibody

    • Catalog No.：YT3186
    • Applications：WB;IF;ELISA
    • Reactivity：Human;Rat;Mouse;
      • Target：
      • NQO1
      • Fields：
      • >>Ubiquinone and other terpenoid-quinone biosynthesis;>>Metabolic pathways;>>Biosynthesis of cofactors;>>Pathways in cancer;>>Chemical carcinogenesis - reactive oxygen species;>>Hepatocellular carcinoma;>>Fluid shear stress and atherosclerosis
      • Gene Name：
      • NQO1
      • Protein Name：
      • NAD(P)H dehydrogenase [quinone] 1
      • Human Gene Id：
      • 1728
      • Human Swiss Prot No：
      • P15559
      • Mouse Swiss Prot No：
      • Q64669
      • Immunogen：
      • The antiserum was produced against synthesized peptide derived from human NQO1. AA range:203-252
      • Specificity：
      • NQO1 Polyclonal Antibody detects endogenous levels of NQO1 protein.
      • Formulation：
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • Source：
      • Polyclonal, Rabbit,IgG
      • Dilution：
      • WB 1:500 - 1:2000. IF 1:50-200 ELISA: 1:10000. Not yet tested in other applications.
      • Purification：
      • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
      • Concentration：
      • 1 mg/ml
      • Storage Stability：
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name：
      • NQO1;DIA4;NMOR1;NAD(P)H dehydrogenase [quinone] 1;Azoreductase;DT-diaphorase;DTD;Menadione reductase;NAD(P)H:quinone oxidoreductase 1;Phylloquinone reductase;Quinone reductase 1;QR1
      • Observed Band(KD)：
      • 31kD
      • Background：
      • This gene is a member of the NAD(P)H dehydrogenase (quinone) family and encodes a cytoplasmic 2-electron reductase. This FAD-binding protein forms homodimers and reduces quinones to hydroquinones. This protein's enzymatic activity prevents the one electron reduction of quinones that results in the production of radical species. Mutations in this gene have been associated with tardive dyskinesia (TD), an increased risk of hematotoxicity after exposure to benzene, and susceptibility to various forms of cancer. Altered expression of this protein has been seen in many tumors and is also associated with Alzheimer's disease (AD). Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008],
      • Function：
      • catalytic activity:NAD(P)H + a quinone = NAD(P)(+) + a hydroquinone.,cofactor:FAD.,enzyme regulation:Inhibited by dicoumarol.,function:The enzyme apparently serves as a quinone reductase in connection with conjugation reactions of hydroquinons involved in detoxification pathways as well as in biosynthetic processes such as the vitamin K-dependent gamma-carboxylation of glutamate residues in prothrombin synthesis.,induction:By dioxin.,mass spectrometry: PubMed:11735396,miscellaneous:Quinone reductase accepts electrons from both NADH and NADPH with equal efficiency.,polymorphism:The Ser-187 polymorphism may be linked to susceptibility to forms of cancers.,similarity:Belongs to the NAD(P)H dehydrogenase (quinone) family.,subunit:Homodimer.,
      • Subcellular Location：
      • Cytoplasm, cytosol .
      • Expression：
      • Colon,Liver,Pooled,
      • Products Images
      • Wang, Ting, et al. "Chemopreventive effects of atractylenolide II on mammary tumorigenesis via activating Nrf2-ARE pathway." Oncotarget 8.44 (2017): 77500.
      • Western Blot analysis of various cells using NQO1 Polyclonal Antibody diluted at 1:2000

      Attributes

      • Code：
      • YT3186
      • Size
      • 40μL / 100μL / 200μL
      • Price$：
      • 150 / 280 / 450
      • Delivery：
      • 2024-07-18
      Order

      Related Products